Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Belli

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitorsFrancesca Corti, Sara Lonardi, Rossana Intini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2024
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trialsEleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
The Oncologist|September 16, 2023
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial PopulationLuca Mazzarella, Federica Giugliano, Eleonora Nicolo, et al.
Breast Cancer Research and Treatment|October 30, 2024
Molecular tumor board in patients with metastatic breast cancerLuca Boscolo Bielo, Elena Guerini Rocco, Edoardo Crimini, et al.
The Oncologist|August 7, 2023
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted AgentsEleonora Nicolò, Paolo Tarantino, Oriana D'Ecclesiis, et al.
Cancers|January 8, 2025
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I UnitAngela Esposito, Edoardo Crimini, Carmen Criscitiello, et al.
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2021
The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitorsFrancesca Corti, Sara Lonardi, Rossana Intini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2024
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trialsEleonora Nicolò, Sara Gandini, Federica Giugliano, et al.
The Oncologist|September 16, 2023
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial PopulationLuca Mazzarella, Federica Giugliano, Eleonora Nicolo, et al.
Breast Cancer Research and Treatment|October 30, 2024
Molecular tumor board in patients with metastatic breast cancerLuca Boscolo Bielo, Elena Guerini Rocco, Edoardo Crimini, et al.
The Oncologist|August 7, 2023
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted AgentsEleonora Nicolò, Paolo Tarantino, Oriana D'Ecclesiis, et al.
Cancers|January 8, 2025
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I UnitAngela Esposito, Edoardo Crimini, Carmen Criscitiello, et al.
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.
Pageof 5